CastleArk Alternatives’s CME Group CME Stock Holding History

CastleArk Alternatives’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,400	Closed	-$657K	–	69
2021 Q3	$657K	Buy	+3,400	New	+$689K	0.03%	239

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

CastleArk Alternatives's CME Position: Q4 2021 in Review

CastleArk Alternatives sold out of CME Group (CME) in Q4 2021, closing a stake of 3,400 shares — an estimated $657K sold.

CastleArk Alternatives first reported a position in CME in Q3 2021 and held it in 1 quarter. The position peaked at $657K in Q3 2021. 1,147 funds tracked by Wall St. Rank hold CME as of Q4 2021.

CastleArk Alternatives reported no remaining CME Group position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 3,400 CME Group shares in Q4 2021, an estimated $657K.
CastleArk Alternatives first reported a position in CME Group in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's CME Group position peaked at $657K in Q3 2021.
1,147 funds tracked by Wall St. Rank held CME Group as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.